Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NB204132

klra3 Antibody, Biotin, Novus Biologicals™
SDP

Catalog No. NB204132 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB204132 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB204132 Supplier Novus Biologicals Supplier No. NBP176335B
Add to Cart
Add to Cart

Description

Rabbit Polyclonal Antibody

klra3 Polyclonal antibody specifically detects klra3 in Mouse, Rat samples. It is validated for Western Blot, ELISA

Specifications

Antigen klra3
Applications Western Blot, ELISA
Classification Polyclonal
Conjugate Biotin
Formulation PBS
Gene Alias 5E6, Klra3 killer cell lectin-like receptor, subfamily A, member 3, Ly49c, Nk2, Nk-2, Nk2.1, NK-2.1
Host Species Rabbit
Immunogen Antibody was raised against a 14 amino acid synthetic peptide near the carboxy terminus of mouse KLRA3. The immunogen is located within the last 50 amino acids of KLRA3. Amino Acid Squence: KLDMKIRKMNFKSR
Purification Method Peptide affinity purified
Quantity 0.1 mL
Regulatory Status RUO
Research Discipline Immunology
Primary or Secondary Primary
Gene ID (Entrez) 16634
Target Species Mouse, Rat
Content And Storage Store at 4°C in the dark.
Form Purified
Isotype IgG
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.